Get the latest Science News and Discoveries

RAS(ON) inhibitor doubles median overall survival in results of phase 3 trial for patients with metastatic pancreatic cancer - EurekAlert!

Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of Results

Results

Photo of patients

patients

Photo of phase

phase

Related news:

A new pancreatic cancer pill may be a game changer for patients

ASCO: Targeted drug outperforms chemotherapy for patients with hard-to-treat lung cancer - EurekAlert!

Taking a second look at surgery eligibility for patients with lung cancer who smoke - EurekAlert!

« Perioperative apalutamide in high-risk localized or locally advanced prostate cancer reduces risk of metastasis and death - EurekAlert!

Ethanol extracts of justicia carnea leaves mitigate pancreatic oxidative stress and preserve islet glucagon expression in TNBS-treated mice - EurekAlert! »